Abacavir and Lamivudine 600 mg/1
Abacavir and Lamivudine · TABLET, FILM COATED · Macleods Pharmaceuticals Limited
Abacavir and Lamivudine is a tablet, film coated containing abacavir and lamivudine at 600 mg/1, taken oral. Manufactured by Macleods Pharmaceuticals Limited.
Key Facts
- Brand Name
- Abacavir and Lamivudine
- Generic Name
- Abacavir and Lamivudine
- NDC Code (Product)
33342-440- Manufacturer
- Macleods Pharmaceuticals Limited
- Strength
- 600 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- ANDA212663
- Drug Class
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
- Marketing Start
- 12/20/2024
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Frequently Asked Questions
What is Abacavir and Lamivudine used for?
Abacavir and Lamivudine contains Abacavir and Lamivudine. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is Abacavir and Lamivudine a controlled substance?
Abacavir and Lamivudine is not classified as a controlled substance by the DEA.
What is the generic name for Abacavir and Lamivudine?
The generic name for Abacavir and Lamivudine is Abacavir and Lamivudine. There are 1 other brand versions of Abacavir and Lamivudine.
What is the NDC code for Abacavir and Lamivudine 600 mg/1?
The NDC (National Drug Code) for Abacavir and Lamivudine 600 mg/1 is 33342-440, listed by Macleods Pharmaceuticals Limited.